Valve materials can degenerate over time after implantation.Expandable valve technology remains an elusive target for congenital heart surgeons. We are learning important lessons from this series.See Article page 84.Congenital heart surgeons unfortunately still find the need to adapt adult prosthetic valves to fit pediatric applications. The manuscript by Griffiths and colleagues highlights the harsh reality that the search for a durable pediatric prosthesis will be fraught with numerous failures. The hypothesis underlying this case series was reasonable—valves designed for transcatheter implantation may function as expandable valves for pediatric applications. After all, experience with a stented bovine jugular vein graft in the mitral or tricuspid position had previously shown promise in this regard. At first glance, one would expect a stented trileaflet bovine pericardial valve to function similarly well. However, this series demonstrated suboptimal performance due to leaflet immobility at relatively short-term follow-up. Mechanical valves remain a viable option for patients with annulus diameter of greater than 15 mm, but the promise of an expandable heart valve for growing children remains elusive.When designing an expandable pediatric heart valve, several considerations arise. First and foremost is leaflet material. Unlike pyrolytic carbon, biological tissues are prone to degradation from cyclic stress and calcification from numerous mechanisms. The “inertia” of the leaflet, attributable to its mass and stiffness, plays important role in the mobility of the leaflet during the cardiac cycle. Infants with low cardiac output compared with adults experience low flow across the valve. Opening forces are less in the atrioventricular valve positions compared with the outflow positions, due to the low driving pressure gradient between the atrium and ventricle during diastole. Poor mobility of a leaflet early after implantation may set the stage for thrombosis, fibrin formation, and pannus ingrowth, which lead to early valve deterioration (Figure 1). Another important consideration is the leaflet configuration for an expandable valve. Venous valves were designed by nature to maintain competence over a range of diameters, and valves that have been modeled based upon the venous valve have shown promise., Essential features of the venous valve include the tall commissural height and hammock-shaped leaflets. Most bovine pericardial valves are designed to function well at a prescribed diameter but may buckle if underexpanded or separate if overexpanded. Given the small size of the pediatric annulus, a minimal valve housing is key to maximizing effective orifice area. Wire mesh stents are ideal in this regard, since they support a valve without occupying much space.
Figure 1
Valve materials can degenerate over time after implantation.
Valve materials can degenerate over time after implantation.The bovine pericardial valve implanted in this series has certain favorable features—excellent effective orifice area, an expandable stent housing that is relatively fracture-resistant, and low rate of endocarditis in adult populations. However, the disadvantages lie in the material properties and valve design. Bovine pericardium is thick and stiff, even after painstaking processing. This leads to poor mobility in the atrioventricular valve position. The design does not accommodate for incomplete expansion, and underexpansion may contribute further to leaflet immobility and deterioration. The lessons learned from this experience will help us in our choice of off-label valve prostheses but more importantly guide future development of pediatric heart valves.
Authors: Paul J Chai; Isaac George; Tamim M Nazif; David M Kalfa; Susheel K Kodali; Alejandro J Torres; Julie A Vincent; Martin B Leon; Emile A Bacha Journal: J Thorac Cardiovasc Surg Date: 2015-09-18 Impact factor: 5.209
Authors: Francesca R Pluchinotta; Breanna L Piekarski; Valentina Milani; Oliver Kretschmar; Phillip T Burch; Lale Hakami; David B Meyer; Frederic Jacques; Olivier Ghez; Matteo Trezzi; Adriano Carotti; Shakeel A Qureshi; Ina Michel-Behnke; James M Hammel; Paul Chai; David McMullan; Bret Mettler; Queralt Ferrer; Mario Carminati; Sitaram M Emani Journal: Circ Cardiovasc Interv Date: 2018-11 Impact factor: 6.546
Authors: Sophie C Hofferberth; Mossab Y Saeed; Lara Tomholt; Matheus C Fernandes; Christopher J Payne; Karl Price; Gerald R Marx; Jesse J Esch; David W Brown; Jonathan Brown; Peter E Hammer; Richard W Bianco; James C Weaver; Elazer R Edelman; Pedro J Del Nido Journal: Sci Transl Med Date: 2020-02-19 Impact factor: 17.956
Authors: Osama M Eltayeb; William J Readdy; Michael C Mongé; Joseph M Forbess; Anne E Sarwark; Angira Patel; Carl L Backer Journal: Ann Thorac Surg Date: 2019-03-27 Impact factor: 4.330
Authors: Sitaram M Emani; Breanna L Piekarski; David Zurakowski; Christopher A Baird; Audrey C Marshall; James E Lock; Pedro J Del Nido Journal: J Thorac Cardiovasc Surg Date: 2016-08-31 Impact factor: 5.209